化学信息:
中文名 | 甘松新酮 |
英文名 | Nardosinone |
中文别名 | - |
英文别名 | - |
来源 | 甘松Nardostachys jatamansi DC. |
化合物类型 | 酮类(Ketones)>脂环酮 |
化学式 | C15H22O3 |
分子量 | 250.33 |
CAS号 | 23720-80-1 |
纯度 | 98%, HPLC |
溶剂/溶解度 | DMSO: 46 mg/ml (183.8 mM) |
溶液配制 | 3mg加入1.20ml DMSO,或者每2.50mg加入1ml DMSO,配制成10mM溶液。 |
生物信息
产品描述 | Nardosinone, isolated from Nardostachys chinensis, is the first enhancer of the neuritogenic action of dbcAMP and staurosporine. Nardosinone may become a useful pharmacological tool for studying the mechanism of action of not only nerve growth factor (NGF) but also both the neuritogenic substances. | ||||
信号通路 | PI3K/Akt; MEK/ERK | ||||
靶点 | - | - | - | - | - |
IC50 | - | - | - | - | - |
体外研究 | Nardosinone (0.1-100 microM) enhanced dibutyryl cyclic AMP (dbcAMP, 0.3 mM)- and staurosporine (10 nM)-induced neurite outgrowth from PC12D cells in a concentration-dependent manner. Nardosinone enhances a downstream step of MAP kinase in the MAP kinase-dependent signaling pathway. Nardosinone has inhibitory effect on Ang II-induced hypertrophy in H9c2 cells, might be mediated by targeting PI3K/Akt and MEK/ERK signaling pathways. Nardosinone could protect against the neuronal injury exposed to OGD, which may be relevant to the promotion of PKA and ERK signaling pathway. Nardosinone enhances staurosporine- or dbcAMP-induced neurite outgrowth from PC12D cells, probably by amplifying both the MAP kinase-dependent and -independent signaling pathways of dbcAMP and staurosporine. The enhancement of NGF-induced neurite outgrowth from PC12D cells by Nardosinone involves activation of a down-stream step of the MAP kinase-dependent cascade of NGF coupled with PKC. | ||||
体内研究 | N/A | ||||
临床实验 | N/A |
1. Li P, et al. Brain Res Dev Brain Res. 2003,145(2):177-83.
2. Du M , Huang K , Gao L , et al. Journal of Huazhong University of Science and Technology, 2013,33(6):822-826.
包装清单:产品编号 | 产品名称 | 包装 |
SM9052-10mM | 甘松新酮(98%, HPLC) | 10mM×0.2ml |
SM9052-5mg | 甘松新酮(98%, HPLC) | 5mg |
SM9052-25mg | 甘松新酮(98%, HPLC) | 25mg |
SM9052-100mg | 甘松新酮(98%, HPLC) | 100mg |
- | 说明书 | 1份 |
-20℃避光保存,至少一年有效。固体粉末4℃避光保存,至少一个月有效。如果溶于非DMSO溶剂,建议分装后-80℃避光保存,预计6个月内有效。
注意事项:本产品可能对人体有一定的毒害作用,请注意适当防护,以避免直接接触人体或吸入体内。
本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。
为了您的安全和健康,请穿实验服并戴一次性手套操作。